Phase II trial of the pan-deacetylase inhibitor panobinostat as a single agent in advanced relapsed/refractory multiple myeloma

Jeffrey L. Wolf, David Siegel, Hartmut Goldschmidt, Katharine Hazell, Priscille M. Bourquelot, Bourras R. Bengoudifa, Jeffrey Matous, Ravi Vij, Margarida De Magalhaes-Silverman, Rafat Abonour, Kenneth C. Anderson, Sagar Lonial

Research output: Contribution to journalLetterpeer-review

109 Scopus citations
Original languageEnglish
Pages (from-to)1820-1823
Number of pages4
JournalLeukemia and Lymphoma
Volume53
Issue number9
DOIs
StatePublished - Sep 2012

Cite this